Second-line therapy for metastatic colorectal cancer

被引：0
|
作者：
Price, Timothy J. [1 ]
机构：
[1] Queen Elizabeth Hosp, Hematol Oncol Unit, Woodville, SA 5011, Australia
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 05期
关键词：
BEVACIZUMAB; TRIAL;
D O I：
10.1016/S1470-2045(15)70169-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：476 / 477
页数：2
相关论文
共 50 条
  • [1] Second-line systemic therapy for metastatic colorectal cancer
    Mocellin, Simone
    Baretta, Zora
    Roque i Figuls, Marta
    Sola, Ivan
    Martin-Richard, Marta
    Hallum, Sara
    Cosp, Xavier Bonfill
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [2] IROX as second-line therapy for metastatic colorectal cancer
    Alberto Sobrero
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 248 - 250
  • [3] Irinotecan in second-line therapy of metastatic colorectal cancer
    Jäger, E
    Jäger, D
    Orth, J
    Knuth, A
    [J]. ONKOLOGIE, 2000, 23 : S15 - S17
  • [4] IROX as second-line therapy for metastatic colorectal cancer
    Sobrero, Alberto
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 248 - 250
  • [5] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [6] Second-line therapy in colorectal cancer
    Berlin, J
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (12): : 21 - 26
  • [7] Second-line management of metastatic colorectal cancer
    Gallagher, David J.
    Kemeny, Nancy
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 25 - 32
  • [8] Second-line therapy of metastatic bladder cancer
    Retz, M.
    Bokemeyer, C.
    [J]. ONKOLOGE, 2012, 18 (11): : 1018 - 1022
  • [9] Options for Second-Line Treatment in Metastatic Colorectal Cancer
    Lee, James J.
    Sun, Weijing
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 46 - 54
  • [10] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345